These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 18583852)

  • 41. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The impact of nurse understaffing on the transmission of hepatitis C virus in a hospital-based hemodialysis unit.
    Saxena AK; Panhotra BR
    Med Princ Pract; 2004; 13(3):129-35. PubMed ID: 15073424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence and risk factors for hepatitis C virus infection in hemodialysis patients in an Iraqi renal transplant center.
    Khattab OS
    Saudi J Kidney Dis Transpl; 2008 Jan; 19(1):110-5. PubMed ID: 18087139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
    Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
    Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of anti-HCV in patients on long-term hemodialysis.
    Oguchi H; Terashima M; Tokunaga S; Kiyosawa K; Tanaka E; Furuta S; Kanno Y; Aizawa T; Nishioka K
    Nihon Jinzo Gakkai Shi; 1990 Mar; 32(3):313-7. PubMed ID: 2113144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute hepatitis C among Japanese hemodialysis patients: a prospective 9-year study.
    Furusyo N; Hayashi J; Kakuda K; Ariyama I; Kanamoto-Tanaka Y; Shimizu C; Etoh Y; Shigematsu M; Kashiwagi S
    Am J Gastroenterol; 2001 May; 96(5):1592-600. PubMed ID: 11374705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
    El-Hazmi MM
    Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and incidence of hepatitis C virus (HCV) in hemodialysis patients: study of risk factors.
    Dentico P; Buongiorno R; Volpe A; Carlone A; Carbone M; Manno C; Proscia F; Pastore G; Schiraldi O
    Clin Nephrol; 1992 Jul; 38(1):49-52. PubMed ID: 1499169
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis C virus infection: an update.
    Al-Faleh FZ
    Saudi J Kidney Dis Transpl; 1995; 6(2):118-21. PubMed ID: 18583847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dialysis centers in the kingdom of saudi arabia.
    Souqiyyeh MZ; Al-Attar MB; Zakaria H; Shaheen FA
    Saudi J Kidney Dis Transpl; 2001; 12(3):293-304. PubMed ID: 18209376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of hepatitis C virus antibodies in hemodialysis patients in madinah Al munawarah.
    Bernieh B; Allam M; Halepota A; Mohamed AO; Parkar J; Tabbakh A
    Saudi J Kidney Dis Transpl; 1995; 6(2):132-5. PubMed ID: 18583851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis C virus infection among hemodialysis patients in the eastern region of saudi arabia.
    Al-Muhanna FA
    Saudi J Kidney Dis Transpl; 1995; 6(2):125-7. PubMed ID: 18583849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and characterization of urolithiasis in the Western region of Saudi Arabia.
    Nassir AM
    Urol Ann; 2019; 11(4):347-352. PubMed ID: 31649451
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prevalence of hypertension in different geographical regions of Saudi Arabia.
    Al-Nozha MM; Osman AK
    Ann Saudi Med; 1998; 18(5):401-7. PubMed ID: 17344710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of occult hepatitis C virus among hemodialysis patients in Tanta university hospitals: a single-center study.
    Abdelmoemen G; Khodeir SA; Abou-Saif S; Kobtan A; Abd-Elsalam S
    Environ Sci Pollut Res Int; 2018 Feb; 25(6):5459-5464. PubMed ID: 29214477
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epidemiology of hepatitis C virus among hemodialysis patients in the Middle East and North Africa: systematic syntheses, meta-analyses, and meta-regressions.
    Harfouche M; Chemaitelly H; Mahmud S; Chaabna K; Kouyoumjian SP; Al Kanaani Z; Abu-Raddad LJ
    Epidemiol Infect; 2017 Nov; 145(15):3243-3263. PubMed ID: 28988562
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.
    Mohamoud YA; Miller FD; Abu-Raddad LJ
    World J Gastroenterol; 2014 Sep; 20(36):12734-52. PubMed ID: 25278675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors of HCV seroconversion in hemodialysis patients in tabriz, iran.
    Somi MH; Etemadi J; Ghojazadeh M; Farhang S; Faramarzi M; Foroutan S; Soleimanpour M
    Hepat Mon; 2014 Jun; 14(6):e17417. PubMed ID: 24976839
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A shield against a monster: Hepatitis C in hemodialysis patients.
    Alavian SM
    World J Gastroenterol; 2009 Feb; 15(6):641-6. PubMed ID: 19222088
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of hepatitis C antibodies among hemodialysis patients in the Western province of saudi arabia.
    Shaheen FA; Huraib SO; Al-Rashed R; Aldrees A; Arif M; Al Jeffry M; Tashkandy MA; Safwat M
    Saudi J Kidney Dis Transpl; 1995; 6(2):136-9. PubMed ID: 18583852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.